Articles written by: Woodward Robert

Arena Pharmaceuticals Inc. (ARNA) and Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) Comparison side by side

Arena Pharmaceuticals Inc. (NASDAQ:ARNA) and Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) have been rivals in the Biotechnology for quite some time. Below is a review of each business including various aspects such as dividends, analyst recommendations, profitability, risk, institutional ownership, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income […]

Reviewing BWX Technologies Inc. (BWXT)’s and Spirit AeroSystems Holdings Inc. (NYSE:SPR)’s results

BWX Technologies Inc. (NYSE:BWXT) and Spirit AeroSystems Holdings Inc. (NYSE:SPR) compete against each other in the Aerospace/Defense Products & Services sector. We will compare them and contrast their dividends, analyst recommendations, profitability, risk, institutional ownership, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Reviewing Phio Pharmaceuticals Corp. (PHIO)’s and EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT)’s results

Both Phio Pharmaceuticals Corp. (NASDAQ:PHIO) and EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT) are each other’s competitor in the Biotechnology industry. Thus the contrast of their analyst recommendations, profitability, risk, dividends, earnings and valuation, institutional ownership. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Phio Pharmaceuticals Corp. […]

Occidental Petroleum Corporation (OXY) and Approach Resources Inc. (NASDAQ:AREX) Contrasting side by side

We are comparing Occidental Petroleum Corporation (NYSE:OXY) and Approach Resources Inc. (NASDAQ:AREX) on their risk, analyst recommendations, institutional ownership, profitability, dividends, earnings and valuation. They both are Independent Oil & Gas companies, competing one another. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Occidental […]

Harpoon Therapeutics Inc. (HARP) and Constellation Pharmaceuticals Inc. (NASDAQ:CNST) Contrasting side by side

This is therefore a comparing of the profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation in Harpoon Therapeutics Inc. (NASDAQ:HARP) and Constellation Pharmaceuticals Inc. (NASDAQ:CNST). The two are both Biotechnology companies that compete with one another. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Comparison of Coherus BioSciences Inc. (CHRS) and Allakos Inc. (NASDAQ:ALLK)

Both Coherus BioSciences Inc. (NASDAQ:CHRS) and Allakos Inc. (NASDAQ:ALLK) are Biotechnology companies, competing one another. We will contrast their analyst recommendations, profitability, risk, institutional ownership, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Coherus BioSciences Inc. 37.10M 38.07 185.05M -3.13 […]

Contrasting of XpresSpa Group Inc. (XSPA) and YogaWorks Inc. (NASDAQ:YOGA)

This is therefore a contrasting of the profitability, analyst recommendations, risk, dividends, earnings and valuation, institutional ownership in XpresSpa Group Inc. (NASDAQ:XSPA) and YogaWorks Inc. (NASDAQ:YOGA). The two are both Personal Services companies that compete with one another. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Contrasting of Gamida Cell Ltd. (GMDA) and Myovant Sciences Ltd. (NYSE:MYOV)

Gamida Cell Ltd. (NASDAQ:GMDA) and Myovant Sciences Ltd. (NYSE:MYOV) compete against each other in the Biotechnology sector. We will compare them and contrast their profitability, analyst recommendations, risk, dividends, earnings and valuation, institutional ownership. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Gamida Cell […]